NEW YORK, Nov. 23, 2022 /PRNewswire/ —
Major players in the market are Bruker, PerkinElmer, Miltenyi Biotec, Aspect Imaging Ltd, Mediso Ltd, LI-COR Biosciences, Life Technologies Corporation, Trifoil Imaging, Promega Corporation, New England Biolabs, MR Solutions Ltd, General Electric, Sofie Biosciences Inc, Biospace Lab, and Agilent Technologies Inc.
Read the full report: https://www.reportlinker.com/p06364862/?utm_source=PRN
The global small animal imaging (in-vivo) market is expected to grow from $2.06 billion in 2021 to $2.27 billion in 2022 at a compound annual growth rate (CAGR) of 10.4%. The Russia–Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, surge in commodity prices, and supply chain disruptions, effecting many markets across the globe. The small animal imaging (in-vivo) market is expected to grow to $3.38 billion in 2026 at a compound annual growth rate (CAGR) of 10.5%.
The small animal imaging (in-vivo) market consists of sales of small animal imaging (in-vivo) products by entities (organizations, sole traders, and partnerships) that are used to observe, define, and quantify normal and pathologic processes in living animal organs and tissues non-invasively. Small animal imaging (in-vivo) refers to the advanced imaging techniques for monitoring cellular activity, pharmacological effects that have been…
